Skip to main content
. 2023 Aug 10;15(8):2121. doi: 10.3390/pharmaceutics15082121

Figure 3.

Figure 3

Evaluation of calix[4]arene vectors efficiency for the delivery of PNA. (A,C) Percentage of fluorescence positive cells in U251 glioma (A) or HT29 colon cancer cell line (C) transfected with an octaarginine functionalized PNA (R8-PNA) or unfunctionalized PNA (naked PNA) used alone or delivered by different calix[4]arene vectors. (B,D) Percentage of fluorescence-positive cells obtained comparing three different batches (Arg-Hex AC) of the same vector (the lead compound Arg-Hex) obtained by three different purification strategies. Results are resented as mean ± S.E.M; statistical differences between groups were compared using a one-way repeated-measures ANOVA. * p < 0.05, ** p < 0.01.